IGF1 and obstructive sleep apnea syndrome: Fiedorczuk et al. found that a total of 14 sets of candidate biomarkers displayed differences in levels or concentrations in OSAHS patients compared to non-OSA controls, and decreased after OSA treatment: IL-6, leptin, IL-8, IGF-1, etc [7].